299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details
臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EUCTR2009-015875-28-IT (EUCTR) | 07/10/2009 | 22/10/2009 | Modulation of intestinal and extraintestinal inflammation in infants with Cystic Fibrosis by early modification of intestinal microflora - Role of intestinal microflora in infants with Cystic Fibrosis | Modulation of intestinal and extraintestinal inflammation in infants with Cystic Fibrosis by early modification of intestinal microflora - Role of intestinal microflora in infants with Cystic Fibrosis | infants with cystic fibrosis MedDRA version: 9.1;Level: SOC;Classification code 10017947 MedDRA version: 9.1;Classification code 10038738 | INN or Proposed INN: Lactic acid producing organisms | UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Italy | ||||
2 | EUCTR2009-011289-27-IT (EUCTR) | 22/04/2009 | 27/04/2009 | Probiotics in Cystic Fibrosis - ND | Probiotics in Cystic Fibrosis - ND | Cystic Fibrosis Patients MedDRA version: 9.1;Level: SOC;Classification code 10017947 | INN or Proposed INN: Lactic acid producing organisms | UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Italy |